These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11161400)
41. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Shigemasa K; Gu L; O'Brien TJ; Ohama K Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731 [TBL] [Abstract][Full Text] [Related]
42. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Syed V; Ho SM Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535 [TBL] [Abstract][Full Text] [Related]
43. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Mok SC; Chan WY; Wong KK; Cheung KK; Lau CC; Ng SW; Baldini A; Colitti CV; Rock CO; Berkowitz RS Oncogene; 1998 May; 16(18):2381-7. PubMed ID: 9620555 [TBL] [Abstract][Full Text] [Related]
44. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Mok SC; Wong KK; Chan RK; Lau CC; Tsao SW; Knapp RC; Berkowitz RS Gynecol Oncol; 1994 Feb; 52(2):247-52. PubMed ID: 8314147 [TBL] [Abstract][Full Text] [Related]
45. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409 [TBL] [Abstract][Full Text] [Related]
46. Mucin gene expression in ovarian cancers. Giuntoli RL; Rodriguez GC; Whitaker RS; Dodge R; Voynow JA Cancer Res; 1998 Dec; 58(23):5546-50. PubMed ID: 9850092 [TBL] [Abstract][Full Text] [Related]
47. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Iyengar TD; Ng S; Lau CC; Welch WR; Bell DA; Berkowitz RS; Mok SC Oncogene; 1999 Jan; 18(1):257-62. PubMed ID: 9926941 [TBL] [Abstract][Full Text] [Related]
49. Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas. Gubbay O; Guo W; Rae MT; Niven D; Langdon SP; Hillier SG Br J Cancer; 2005 May; 92(10):1927-33. PubMed ID: 15870720 [TBL] [Abstract][Full Text] [Related]
50. Human ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesion. Carreiras F; Cruet S; Staedel C; Sichel F; Gauduchon P Gynecol Oncol; 1999 Mar; 72(3):312-22. PubMed ID: 10053101 [TBL] [Abstract][Full Text] [Related]
51. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075 [TBL] [Abstract][Full Text] [Related]
52. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Russell PA; Pharoah PD; De Foy K; Ramus SJ; Symmonds I; Wilson A; Scott I; Ponder BA; Gayther SA Int J Cancer; 2000 Aug; 87(3):317-21. PubMed ID: 10897034 [TBL] [Abstract][Full Text] [Related]
53. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. Hatta Y; Takeuchi S; Yokota J; Koeffler HP Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043 [TBL] [Abstract][Full Text] [Related]
54. [An "ariditary" form of ovarian cancer]. Birnbaum DJ; Sabatier R; Mamessier É; Birnbaum D; Bertucci F Med Sci (Paris); 2010 Dec; 26(12):1040-2. PubMed ID: 21187041 [No Abstract] [Full Text] [Related]
55. Mos oncogene expression in human ovarian tumors. Xerri L; Charpin C; Hassoun J; Birnbaum D; Delapeyriere O Anticancer Res; 1991; 11(4):1629-34. PubMed ID: 1836123 [TBL] [Abstract][Full Text] [Related]
56. Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. Roberts D; Williams SJ; Cvetkovic D; Weinstein JK; Godwin AK; Johnson SW; Hamilton TC DNA Cell Biol; 2002 Jan; 21(1):11-9. PubMed ID: 11879576 [TBL] [Abstract][Full Text] [Related]
57. Mutational analysis of VACM-1/cul5 exons in cancer cell lines. Lewis SP; Willis AN; Johnson AE; Resau J; Burnatowska-Hledin MA APMIS; 2011 Jul; 119(7):421-30. PubMed ID: 21635549 [TBL] [Abstract][Full Text] [Related]
58. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines. King BL; Carter D; Foellmer HG; Kacinski BM Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236 [TBL] [Abstract][Full Text] [Related]
59. Mutation analysis of the hMTH1 gene in sporadic human ovarian cancer. Takama F; Kanuma T; Wang D; Nishida JI; Nakabeppu Y; Wake N; Mizunuma H Int J Oncol; 2000 Sep; 17(3):467-71. PubMed ID: 10938385 [TBL] [Abstract][Full Text] [Related]
60. The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. Liu Y; Dodds P; Emilion G; Mungall AJ; Dunham I; Beck S; Wells RS; Charnock FM; Ganesan TS BMC Genet; 2002 Oct; 3():20. PubMed ID: 12381271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]